0001493152-22-017154.txt : 20220617
0001493152-22-017154.hdr.sgml : 20220617
20220617160539
ACCESSION NUMBER: 0001493152-22-017154
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220616
FILED AS OF DATE: 20220617
DATE AS OF CHANGE: 20220617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NEIL GARRY ARTHUR
CENTRAL INDEX KEY: 0001586785
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15006
FILM NUMBER: 221023765
MAIL ADDRESS:
STREET 1: 555 CALIFORNIA STREET
STREET 2: SUITE 365
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celldex Therapeutics, Inc.
CENTRAL INDEX KEY: 0000744218
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 133191702
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 53 FRONTAGE ROAD
STREET 2: SUITE 220
CITY: HAMPTON
STATE: NJ
ZIP: 08827
BUSINESS PHONE: 908-200-7500
MAIL ADDRESS:
STREET 1: 53 FRONTAGE ROAD
STREET 2: SUITE 220
CITY: HAMPTON
STATE: NJ
ZIP: 08827
FORMER COMPANY:
FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19980828
FORMER COMPANY:
FORMER CONFORMED NAME: T CELL SCIENCES INC
DATE OF NAME CHANGE: 19920703
4
1
ownership.xml
X0306
4
2022-06-16
0
0000744218
Celldex Therapeutics, Inc.
CLDX
0001586785
NEIL GARRY ARTHUR
C/O CELLDEX THERAPEUTICS, INC.
53 FRONTAGE ROAD, SUITE 220
HAMPTON
NJ
08827
1
0
0
0
Non-Qualified Stock Option (right to buy)
22.48
2022-06-16
4
A
0
27200
0.00
A
2032-06-16
Common Stock
27200
27200
D
Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.
One third vests on the first, second and third anniversaries of the date of grant.
/s/ Sam Martin, attorney-in-fact for Garry A. Neil, M.D.
2022-06-17